Cargando…
Hepatitis B Virus Blood Screening: Need for Reappraisal of Blood Safety Measures?
Over the past decades, the risk of HBV transfusion–transmission has been steadily reduced through the recruitment of volunteer donors, the selection of donors based on risk-behavior evaluation, the development of increasingly more sensitive hepatitis B antigen (HBsAg) assays, the use of hepatitis B...
Autores principales: | Candotti, Daniel, Laperche, Syria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826332/ https://www.ncbi.nlm.nih.gov/pubmed/29515997 http://dx.doi.org/10.3389/fmed.2018.00029 |
Ejemplares similares
-
Early MinION(™) nanopore single-molecule sequencing technology enables the characterization of hepatitis B virus genetic complexity in clinical samples
por: Sauvage, Virginie, et al.
Publicado: (2018) -
Anti‐HBc‐nonreactive occult hepatitis B infections with HBV genotypes B and C in vaccinated immunocompetent adults
por: Deng, Xuelian, et al.
Publicado: (2022) -
Occult HBV infection in Chinese blood donors: role of N-glycosylation mutations and amino acid substitutions in S protein transmembrane domains
por: Zhang, Lu, et al.
Publicado: (2019) -
Reappraisal of screening strategy in hepatitis B surface antigen-negative blood donors: Correlation with hepatitis B virus-DNA quantification
por: Alam, Md. Sohrab, et al.
Publicado: (2022) -
Insights on 21 Years of HBV Surveillance in Blood Donors in France
por: Cappy, Pierre, et al.
Publicado: (2022)